Clinic
Prince William Pediatrics and Adolescent Center
Prince William Pediatrics and Adolescent Center was paid $5.06M by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoPRINCE WILLIAM PEDIATRICS AND ADOLESCENT CENTER
WOODBRIDGE, VA 22192
WOODBRIDGE, VA 22192
33aNPI1689965865assigned 04/22/2011
33bProvider typePrimary Care Clinic/Center
28Total paid$5.06M
24GClaims171,473
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Virginia
Rank by total paid#2 of 80
Median peer was paid$108K
This provider vs. median47×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,650 | $644K | |
| 2019 | 20,473 | $569K | |
| 2020 | 19,738 | $577K | |
| 2021 | 23,507 | $694K | |
| 2022 | 27,654 | $825K | |
| 2023 | 30,009 | $883K | |
| 2024incomplete | 28,442 | $872K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 28,181 | 23,903 | $1.63M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 9,253 | 8,602 | $791K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.4% | 5,123 | 4,995 | $374K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.3% | 4,935 | 4,773 | $368K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.0% | 4,652 | 3,917 | $304K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.3% | 3,375 | 3,274 | $269K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.2% | 3,711 | 3,566 | $112K |
| 92551 | 1.8% | 10,780 | 10,442 | $90K | |
| 90651 | 1.8% | 2,244 | 2,174 | $89K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 5,324 | 3,077 | $84K |
| 90670 | 1.4% | 2,892 | 2,763 | $69K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 1,802 | 1,723 | $59K |
62 more codes
| 99188 | 1.0% | 2,993 | $52K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 3,851 | $51K |
| 90716 | <1% | 2,023 | $50K | |
| 90698 | <1% | 2,663 | $46K | |
| 99381 | <1% | 824 | $45K | |
| 90680 | <1% | 2,304 | $38K | |
| 90621 | <1% | 883 | $35K | |
| 90707 | <1% | 1,899 | $35K | |
| 81002 | <1% | 12,624 | $35K | |
| 90671 | <1% | 619 | $33K | |
| 90734 | <1% | 1,231 | $32K | |
| 90633 | <1% | 2,356 | $30K | |
| 97802 | <1% | 14,262 | $28K | |
| 90744 | <1% | 2,246 | $25K | |
| 90686 | <1% | 2,293 | $25K | |
| 99173 | <1% | 10,744 | $21K | |
| 90674 | <1% | 1,033 | $20K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 8,266 | $19K |
| 90715 | <1% | 1,144 | $16K | |
| 90656 | <1% | 1,277 | $15K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 202 | $15K |
| 99383 | <1% | 187 | $15K | |
| 0001A | <1% | 327 | $12K | |
| 0002A | <1% | 273 | $10K | |
| 90696 | <1% | 607 | $10K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 988 | $10K |
| 0072A | <1% | 230 | $9K | |
| 90619 | <1% | 139 | $9K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 65 | $8K |
| 90700 | <1% | 595 | $7K | |
| 0071A | <1% | 178 | $7K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 526 | $6K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 77 | $6K |
| 90461 | <1% | 3,072 | $5K | |
| 90655 | <1% | 426 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 287 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 115 | $4K |
| 94664 | <1% | 288 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 42 | $3K |
| 83655 | <1% | 260 | $3K | |
| 99384 | <1% | 33 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 55 | $2K |
| 90648 | <1% | 251 | $2K | |
| 90733 | <1% | 89 | $2K | |
| 94760 | <1% | 1,673 | $2K | |
| 99442 | <1% | 55 | $2K | |
| 99401 | <1% | 47 | $2K | |
| 99000 | <1% | 596 | $1K | |
| 99382 | <1% | 12 | $1K | |
| 99051 | <1% | 278 | $1K | |
| 85018 | <1% | 426 | $951.97 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 90 | $893.84 |
| 90710 | <1% | 17 | $601.83 | |
| 87807 | <1% | 54 | $541.46 | |
| 0003A | <1% | 14 | $280.00 | |
| 90713 | <1% | 14 | $239.48 | |
| 96380 | <1% | 17 | $193.20 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 28 | $44.20 |
| 91307 | <1% | 322 | $2.11 | |
| 91300 | <1% | 299 | $1.99 | |
| 91308 | <1% | 18 | $0.16 | |
| 99072 | 0% | 394 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJADIDI, ALI (DIRECTOR)